J&J, Takeda, Orbimed consortium win biotech incubator tender

BioBoost, a consortium of OrbiMed Advisors LLC, Johnson and Johnson (NYSE: JNJ) and Takeda Pharmaceutical Co. Ltd. (TSE: 4502) has won the tender to establish the life sciences incubator as part of the Office of the Chief Scientist’s incubator program.

Orbimed Israel senior managing director Dr. Nissim Darvish said, “The intention is to create a network of companies, each of which stands on its own, but will have ties between them. We are not limiting ourselves to any field, especially not fields in which Johnson and Johnson and Takeda operate. We are aiming for companies that will make money. The incubator is not designed to fill the corporations’ products pipeline.”

You can read more here